Managed funds underperform in December quarter
Australian managed funds on average failed to outperform their respective indices in the December quarter in every major category except small companies funds, according to Morningstar's latest managed fund league performance tables.
"October's rally after a dismal third quarter gave way to deteriorating conditions later in the quarter, which reduced the returns from most managed fund categories," said Morningstar senior research analyst Julian Robertson.
Resources stocks particularly suffered, with the S&P/ASX Resources Index down 2.55 per cent, according to Morningstar.
The outperformance of the smaller companies funds over the S&P/ASX Small Ordinaries Index over the quarter and the 2011 calendar year demonstrated the greater opportunities for value-add in this less-researched market segment, Morningstar stated.
Overall there was a narrow dispersion of returns in the large-cap Australian shares sector, where only 40 of the 103 large-cap Australian share funds in the tables managed to beat the benchmark over the quarter.
The best-performed sector was property, with global-listed property funds gaining 8.86 per cent for the quarter, and Australian-listed property outperforming the wider Australian share market.
Fixed income returns were modestly positive at around 2 per cent but most did not surpass their benchmarks in the quarter.
Recommended for you
As the year draws to a close, a new report has explored the key trends and areas of focus for financial advisers over the last 12 months.
Assured Support explores five tips to help financial advisers embed compliance into the heart of their business, with 2025 set to see further regulatory change.
David Sipina has been sentenced to three years under an intensive correction order for his role in the unlicensed Courtenay House financial services.
As AFSLs endeavour to meet their breach reporting obligations, a legal expert has emphasised why robust documentation will prove fruitful, particularly in the face of potential regulatory investigations.
